Not yet recruitingInterventionalNot ApplicableLast updated Apr 2, 2026

Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma

Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma: A Prospective Phase II Clinical Trial

Overview

ClinicalTrials.gov ID: NCT07507058
Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER
Brief Summary: This study aims to evaluate the safety and efficacy of hypofractionated radiotherapy in patients with postoperative intermediate-risk head and neck squamous cell carcinoma.
Study Type: Interventional

Status

Study Record Dates

NCT04403620Active, not recruiting

HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer

NCT06630780Recruiting

Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma

NCT04284540Completed

Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma

NCT06768125Enrolling by invitation

Hypofractionated Radiotherapy for HNSCC in Elderly Patients

NCT00188318Completed

Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)

NCT00771641Completed

Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck